(Q87261695)
English
Long-term safety and efficacy of tofogliflozin, a selective inhibitor of sodium-glucose cotransporter 2, as monotherapy or in combination with other oral antidiabetic agents in Japanese patients with type 2 diabetes mellitus: multicenter, open-label
scientific article published on 11 February 2014
Statements
Long-term safety and efficacy of tofogliflozin, a selective inhibitor of sodium-glucose cotransporter 2, as monotherapy or in combination with other oral antidiabetic agents in Japanese patients with type 2 diabetes mellitus: multicenter, open-label, randomized controlled trials (English)
Yukio Tanizawa
Kohei Kaku
Eiichi Araki
Kazuyuki Tobe
Yasuo Terauchi
Kazunori Utsunomiya
Yasuhiko Iwamoto
Wataru Ohtsuka
Daisuke Watanabe
Hideki Suganami
Tofogliflozin 004 and 005 Study group
11 February 2014